A phase I trial of bortezomib with temozolomide in patients with advanced melanoma: toxicities, antitumor effects, and modulation of therapeutic targets.

Source:http://linkedlifedata.com/resource/pubmed/id/20028756

Clin. Cancer Res. 2010 Jan 1 16 1 348-57

Download in:

View as

Triples

General Info

PMID
20028756